Masimo Corporation · NASDAQ:MASI

Masimo — Q1 2018 Earnings Presentation

15 slides from Masimo's earnings presentation, May 2, 2018

  1. Slide 1: Q1 2018 Results Supplemental Presentation to Earnings Press Release

    © 2017 Masimo. All Rights Reserved. Q1 2018 Results Supplemental Presentation to Earnings Press Release May 2, 2018

  2. Slide 2: Forward-Looking Statements

    © 2018 Masimo. All Rights Reserved. All statements other than statements of historical facts contained herein that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements

  3. Slide 3: Non-GAAP Financial Measures

    © 2018 Masimo. All Rights Reserved. Non-GAAP Financial Measures The non-GAAP financial measures contained herein are a supplement to the corresponding financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP). The non-GAAP financial measures presented exclud

  4. Slide 4: Impact of Adoption of New Accounting Standard (ASC 606)

    © 2018 Masimo. All Rights Reserved. Impact of Adoption of New Accounting Standard (ASC 606) During the first quarter of 2018, the Company adopted Financial Accounting Standards Board (FASB) Accounting Standards Update No. 2014-09, Revenue (Topic 606): Revenue from Contracts with Customers (ASU 2014-

  5. Slide 5: Masimo Today

    © 2018 Masimo. All Rights Reserved. Masimo Today ~$818M annual product revenue 1 >140 countries Innovator in noninvasive patient monitoring technologies >100 Million patients impacted each year 2 Leader in pulse oximetry Primary pulse oximetry technology at 17 of the top 20 hospitals listed in the 2

  6. Slide 6: Progress on New Seven Year Plan

    © 2018 Masimo. All Rights Reserved. ► Our customers and partners are embracing us ► Targeting long-term revenue growth of 8%-10% ► Targeting long-term operating profit margin of 30% ► Targets do not include contributions from products in pipeline or M&A ► We are a 29 year-old company that has the pa

  7. Slide 7: First Quarter 2018 Financial Results

    © 2018 Masimo. All Rights Reserved. First Quarter 2018 Financial Results

  8. Slide 8: First Quarter 2018 Highlights

    © 2018 Masimo. All Rights Reserved. First Quarter 2018 Highlights 1 ► Total revenue, including royalty and other revenue of $213.0 million ► Product revenue increased to $204.4 million ► GAAP net income of $45.6 million, or $0.82 cent per diluted share, which included a tax benefit related to stock

  9. Slide 9: First Quarter 2018 Performance

    © 2018 Masimo. All Rights Reserved. ($ in millions, except %’s and per share amounts) Q1 2018 Actual Q1 2017 Actual % Growth vs. Prior Year ASC 605 as reported ASC 606 adjustments ASC 606 as adjusted ASC 605 as reported ASC 606 as adjusted Product revenue 204.4 178.1 4.3 182.4 14.8% 12.0% Royalty an

  10. Slide 10: 2018 Guidance

    © 2018 Masimo. All Rights Reserved. 2018 Guidance

  11. Slide 11: 2018 Updated Financial Guidance

    © 2018 Masimo. All Rights Reserved. 2018 Updated Financial Guidance 1,2 ($ in millions, except %’s and per share amounts) 2018 Updated Guidance Performance HighlightsGAAP Non-GAAP 2 Total Revenue $ 846 $ 846 Product Revenue $ 818 $ 818 Non-GAAP product revenue increasing 10.8% (or ~10% Ex Fx) to $81

  12. Slide 12: Updated FY 2018 Guidance

    © 2018 Masimo. All Rights Reserved. ($ in millions, except %’s and per share amounts) Updated 2018 Guidance FY 2017 Actual % Growth vs. Prior Year ASC 605 as reported ASC 606 adjustments ASC 606 as adjusted ASC 605 as reported ASC 606 as adjusted Product revenue 818.0 741.3 (3.1) 738.2 10.3% 10.8% R

  13. Slide 13: Driving Shareholder Value Through Growth and Profitability

    © 2018 Masimo. All Rights Reserved. Driving Shareholder Value Through Growth and Profitability Product Revenue 2 (in Millions) Adjusted EBITDA 2 (in Millions) Non-GAAP EPS 2 ($ per share) 1 1 1 1 Masimo 2018 financial guidance as of May 2, 2018 2 Please refer to our Non-GAAP financial measures and d

  14. Slide 14: Investment Highlights

    © 2018 Masimo. All Rights Reserved. Investment Highlights Improve Patient Care and Reduce Cost of Care through Innovation-Ultimate Way to Drive Shareholder Value Grow revenues at multiples of the market (8-10% growth) Target long-term gross product margins of ~70% and operating profit margins of ~30

  15. Slide 15: © 2018 Masimo. All Rights Reserved.

    © 2018 Masimo. All Rights Reserved.

Masimo — Q1 2018 Earnings Presentation on 6ix